A price cap on insulin from one of the three major manufacturers took effect on New Year's Day, giving more Americans with diabetes more affordable treatments. As of Jan. 1, 2024, Sanofi cut the ...

Eli Lilly, the first to announce insulin price cuts this month, will slash the drugmaker's most commonly prescribed insulin Humalog to $66.40 per vial, down from $274.70. It will implement price ...

Ricks said Eli Lilly backs legislation that would impose a $35 per month price cap for insulin covered under private health insurance plans. "We are left in 2023 with a split situation," he said.

Eli Lilly's price cuts on insulin will increase its profits, thanks to America's bizarre drug pricing system. Don't mistake its move for philanthropy.

In response to public pressure and changing market dynamics, the trio of major manufacturers slashed insulin prices by 70% or more last year. While diabetes patients applauded the price cuts, a ...

In other words, insulin manufacturers have been dropping their prices because of old-fashioned competition. And that’s largely solved the problem the proposed out-of-pocket cap is meant to fix.

Insulin prices averaged 19 cents per unit as of the quarter started Oct. 2024, marking the lowest level recorded in a decade, according to research from GoodRx, based on sources such as pharmacies ...

With Medicare annual open enrollment about to close on Dec. 7, Medicare experts are discovering many insurance plans are dropping some insulin coverage in 2024.. In an informal survey of 22 Medicare ...

Last fall, after the 340B discount changed, she was quoted $490 at her pharmacy — the retail price for a box of insulin pens. Erie Health sent her to another pharmacy, ...

A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price increases after President Donald Trump rescinded a 2022 executive order on ...